Your browser doesn't support javascript.
loading
Non-alcoholic fatty liver disease in diabetes: When to refer to the hepatologist?
Khandelwal, Reshu; Dassanayake, Anuradha S; Conjeevaram, Hari S; Singh, Shivaram P.
Afiliación
  • Khandelwal R; Department of Gastroenterology, Srirama Chandra Bhanja (SCB) Medical College and Hospital, Cuttack 753007, Odisha, India.
  • Dassanayake AS; Department of Medicine, Colombo North Centre for Liver Disease, University of Kelaniya, Kelaniya 11600, Sri Lanka.
  • Conjeevaram HS; Division of Gastroenterology and Hepatology, University of Michigan Medical School, Ann Arbor, MI 48109, United States.
  • Singh SP; Department of Gastroenterology, Srirama Chandra Bhanja (SCB) Medical College and Hospital, Cuttack 753007, Odisha, India. scb_gastro_dept@hotmail.com.
World J Diabetes ; 12(9): 1479-1493, 2021 Sep 15.
Article en En | MEDLINE | ID: mdl-34630901
Non-alcoholic fatty liver disease (NAFLD) has become one of the most common chronic liver diseases worldwide. A strong relationship exists between NAFLD and diabetes mellitus. There is growing evidence of a mechanistically complex and strong association between the two diseases. Current data also shows that one disease actually leads to worsening of the other and vice versa. Understanding of the various pathophysiological mechanisms involved, natural history and spectrum of these two diseases is essential not only for early diagnosis and management but also for prevention of severe disease forms. Despite the tremendous progress made in recent times in acquiring knowledge about these highly prevalent diseases, the guidelines and recommendations for screening and management of diabetics with NAFLD remain ambiguous. An interdisciplinary approach is required to not only raise awareness of the prevalence of NAFLD in diabetics but also for better patient management. This can help attenuate the development of significant complications, such as cirrhosis, decompensation and hepatocellular carcinoma in these patients, thereby halting NAFLD in its tracks. This review focuses on the pivotal role of primary care physicians and endocrinologists in identification of NAFLD in diabetics in early stages and the role of proactive screening for prompt referral to hepatologist.
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Guideline / Prognostic_studies / Risk_factors_studies / Screening_studies Idioma: En Revista: World J Diabetes Año: 2021 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Guideline / Prognostic_studies / Risk_factors_studies / Screening_studies Idioma: En Revista: World J Diabetes Año: 2021 Tipo del documento: Article